For example, Bozdoğan et al. encapsulated siRNA using diphenylalaninamide-based nanoparticles to silence human epidermal growth factor receptor-2 (HER2), a carcinogene playing a role in the development of some breast cancers. This evidence concerns the gene ERBB2 and breast carcinoma.